The local-to-global initiative will support healthcare innovation and technological advancement for comprehensive solutions catering to healthcare needs Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a US$300 billion Bio-economy by 2030
Dr Pradeep Mahajan, Regenerative Medicine Researcher & Founder of StemRx BioScience Solutions India. In the wake of the COVID-19 pandemic, the world witnessed an unprecedented health crisis that affected millions of lives. While many individuals recovered from the infection, some continue to experience long-term complications. One
Global pharma major Lupin Limited (Lupin) today announced that its Unit-2 manufacturing facility located in Mandideep, India, has successfully completed a GMP inspection by the United States Food and Drug Administration (U.S. FDA). The inspection was conducted from August 7 to August 11, 2023 and concluded
Nationwide vaccination camps at around 100 centers; Rabies accounts for 90% of Zoonotic cases in India Indian Immunologicals Limited (IIL), one of India's leading biotechnology companies dedicated to manufacturing and supplying life-saving vaccines, commemorated World Zoonoses Day on July 6th, 2023. This significant occasion highlights
-First batch of 100 students of BAMS inducted at AIIA Goa Goa: Induction programme of the first batch of 100 BAMS (Bachelor of Ayurvedic Medicine and Surgery) students of the recently inaugurated satellite institute of All India Institute of Ayurveda (AIIA) in Goa was organized on Monday. Addressing
Global pharma major Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg, to market a generic equivalent of Slynd® Tablets, 4 mg, of Exeltis USA Inc. Drospirenone
Thermo Fisher Scientific, the world leader in serving science, has once again cemented its place among the best workplaces in India. For the fourth straight year, Thermo Fisher Scientific India has been recognized by the Great Place to Work® Institute (GPTW) for sustaining a High-Trust,
Singapore based company Neuome Peptides Pte Ltd, a start-up backed by Mercatus Capital Singapore has developed a Peptide-based rapid antigen test kit, TruCov-Flow. This technology detects SARS-CoV-2 virus from saliva thus removing the need for swab and results come within 3-5 minutes maximum. It is ICMR validated and approved
Strengthens offerings & continues to be at the forefront of COVID care Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems
